Course Description

Understanding GLP-1 Agonists: Ozempic

Presented by 1st-year Emory medical students, this session provides an engaging overview of GLP-1 receptor agonists, focusing on Ozempic (Semaglutide). The students will discuss its mechanism of action, role in managing type 2 diabetes and obesity, and emerging research on its broader applications. The presentation also covers benefits, potential side effects, and practical considerations for patients and providers. Designed to simplify complex concepts, this talk offers valuable insights for anyone curious about cutting-edge advancements in diabetes care.

The information presented is what our 1st year Med students are studying in their curriculum.